Assenagon Asset Management S.A. Buys 12,058 Shares of Cencora, Inc. $COR

Assenagon Asset Management S.A. lifted its stake in shares of Cencora, Inc. (NYSE:COR) by 5.0% during the first quarter, HoldingsChannel.com reports. The fund owned 255,574 shares of the company’s stock after buying an additional 12,058 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Cencora were worth $80,286,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of COR. Kemnay Advisory Services Inc. purchased a new stake in shares of Cencora in the fourth quarter valued at approximately $25,000. Oakworth Capital Inc. purchased a new position in Cencora during the 4th quarter worth $26,000. Elyxium Wealth LLC purchased a new position in Cencora during the 4th quarter worth $27,000. Archer Investment Corp raised its position in Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. Finally, Motiv8 Investments LLC bought a new stake in Cencora during the 4th quarter valued at $29,000. Institutional investors own 97.52% of the company’s stock.

Wall Street Analysts Forecast Growth

COR has been the topic of a number of recent research reports. Robert W. Baird dropped their price target on Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research report on Thursday, May 7th. Leerink Partners restated an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Bank of America upped their price objective on shares of Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a research note on Wednesday. Weiss Ratings cut shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. Finally, Barclays cut their target price on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 10th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $367.75.

Insider Buying and Selling at Cencora

In other news, Director Lauren M. Tyler purchased 550 shares of the stock in a transaction dated Monday, June 22nd. The shares were acquired at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the acquisition, the director owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. This represents a 14.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.38% of the company’s stock.

Cencora Trading Up 1.4%

COR opened at $284.94 on Thursday. The firm has a market cap of $55.44 billion, a price-to-earnings ratio of 21.85, a PEG ratio of 1.52 and a beta of 0.59. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a 12 month low of $244.82 and a 12 month high of $377.54. The stock has a fifty day moving average price of $282.09 and a 200-day moving average price of $322.80.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter last year, the company earned $4.42 earnings per share. The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities research analysts anticipate that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio is presently 18.40%.

Cencora announced that its Board of Directors has authorized a stock buyback plan on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to repurchase up to 3.9% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.